Revolution Medicines (RVMD)
(Delayed Data from NSDQ)
$47.94 USD
+1.80 (3.90%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $47.91 -0.03 (-0.06%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth F Momentum F VGM
Earnings News For RVMD
-
Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress
-
Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Lags Revenue Estimates
-
Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress
-
Revolution Medicines, Inc. (RVMD) Reports Q3 Loss, Lags Revenue Estimates
-
Revolution Medicines Reports Third Quarter 2023 Financial Results and Update on Corporate Progress
-
Revolution Medicines, Inc. (RVMD) Reports Q2 Loss, Misses Revenue Estimates
-
Revolution Medicines Reports Second Quarter 2023 Financial Results and Update on Corporate Progress
-
Revolution Medicines, Inc. (RVMD) Reports Q1 Loss, Tops Revenue Estimates
-
Revolution Medicines Reports First Quarter 2023 Financial Results and Update on Corporate Progress
-
Revolution Medicines, Inc. (RVMD) Expected to Beat Earnings Estimates: Should You Buy?
-
Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Tops Revenue Estimates
-
Revolution Medicines Reports Fourth Quarter and Full Year 2022 Financial Results and Update on Corporate Progress
-
Revolution Medicines, Inc. (RVMD) Reports Q3 Loss, Misses Revenue Estimates
-
Revolution Medicines Reports Third Quarter 2022 Financial Results and Update on Corporate Progress
-
Revolution Medicines, Inc. (RVMD) Reports Q2 Loss, Tops Revenue Estimates
-
Revolution Medicines, Inc. (RVMD) Reports Q1 Loss, Misses Revenue Estimates
-
Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Tops Revenue Estimates
-
Revolution Medicines, Inc. (RVMD) Reports Q3 Loss, Lags Revenue Estimates
-
Earnings Preview: Revolution Medicines, Inc. (RVMD) Q3 Earnings Expected to Decline
-
Revolution Medicines, Inc. (RVMD) Reports Q2 Loss, Misses Revenue Estimates
-
Earnings Preview: Revolution Medicines, Inc. (RVMD) Q2 Earnings Expected to Decline
-
Revolution Medicines, Inc. (RVMD) Reports Q1 Loss, Tops Revenue Estimates
-
Revolution Medicines, Inc. (RVMD) May Report Negative Earnings: Know the Trend Ahead of Q1 Release